Case series of outcomes in advanced cancer patients with single pathway alterations receiving N-of-One therapies

Though advanced cancers generally display complex molecular portfolios, there is a subset of patients whose malignancies possess only one genomic alteration or alterations in one oncogenic pathway. We assess how N-of-One therapeutic strategies impact outcomes in these patients. From 12/2012 to 9/201...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Diviya, Kurzrock, Razelle, Lee, Suzanna, Okamura, Ryosuke, Lim, Hyo Jeong, Kim, Ki Hwan, Sicklick, Jason K., Kato, Shumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960821/
https://www.ncbi.nlm.nih.gov/pubmed/35347205
http://dx.doi.org/10.1038/s41698-022-00259-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960821/
https://www.ncbi.nlm.nih.gov/pubmed/35347205
http://dx.doi.org/10.1038/s41698-022-00259-7

Ejemplares similares